Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorAssiut University
The association of metabolic associated fatty liver disease in patients with chronic glomerular disease
All CKD patient aging between (18-70) years with known tubule-glomerular diseases.
At any eGFR.
All CKD patient have either type I/II DM associated with CKD .
CKD patients of Unknown etiology.
CKD patients with liver cirrhosis.
CKD patients secondry to documented diabetic nephropathy.
Patients with previous/current HBV or HCV.